|
AZA
|
MMF
|
No IS
|
---|
Hemoglobin, mmol/l
|
7.9 (5.5-10.4)
|
8.2 (5.4-10.7)
|
8.2 (4.5-10.7)
|
Platelets/µl
|
238 (48-459)
|
252 (136-404)
|
223 (96-379)
|
Leukocytes
|
4855 (2,060-10,160)
|
5970 (2,640-15,550)
|
5225 (2,080-9,050)
|
Lymphocytes/µl
|
987 (200-3,790)
|
1080 (360-3,010)
|
1330 (300-2,910)
|
B cells %
|
4.5 (0.6-31.3)* §§§
|
9.4 (0.6-40.1)*
|
11.8 (3.6-28.9)§§§
|
B cells/µl
|
44(3-662)** §§§
|
113(4-462)**
|
119 (40-460)§§§
|
T % of L
|
76 (28-93)*
|
63 (24-85)*
|
64 (42,2-84,5)
|
T/µl
|
584 (180-3,286)
|
640 (89-2,468)
|
807 (162-2,104)
|
CD4+ %
|
73 (39-82)
|
71 (41-92)
|
69 (33-92)
|
CD4+/µl
|
430 (85-1,709)
|
466 (61-2,021)
|
518 (106-1,514)
|
CD8+ %
|
19 (7-46)
|
22 (3-48)
|
22 (2-60)
|
CD8+/µl
|
127 (25-1,410)
|
144 (12-696)
|
207 (19-604)
|
CD4-/CD8- %
|
6 (2-18)
|
6 (2-11)
|
5 (2-20)
|
CD4-/CD8- /µl
|
41 (8-136)
|
41 (2-139)
|
46 (4-137)
|
- Results are presented as median (range). Statistically significant differences detected between cell counts of patients taking azathioprine (AZA) and mycophenolate mofetil (MMF) (*P < 0.05, **P < 0.01, ***P < 0.001) and AZA compared to patients not taking immunosuppressive therapy §P < 0.05, §§P < 0.01, §§§P < 0.001 (Dunn's multiple comparison test).